Lee, Hyungwoo
Jang, Hyoik
Chae, Jae-Byoung
Lee, Hyo Kyung
Son, Chanok
Park, Chul-Woo
Ha, Taejeong
Yum, Munjeong
Park, Sungmi
Hong, Sun Woo
Lee, Suk Young
Lyu, Jungmook
Lee, Semin
Lee, Dong Ki
Chung, Hyewon
Funding for this research was provided by:
National Research Foundation of Korea (RS-2024-00453840, NRF-2019M3A9H1030948)
Article History
Received: 21 January 2025
Accepted: 13 June 2025
First Online: 26 July 2025
Competing interests
: H.J., T.H., M.Y., S.P., S.W.H., and D.K.L. are employees of OliX Pharmaceuticals Inc. H.C. serves as a consultant for OliX Pharmaceuticals Inc. A related patent application has been filed: PCT/KR2021/018460. The remaining authors - H.L., J.C., H.K.L., C.S., C.P., S.Y.L., J.L., and S.L. - declare no competing interests.